Cellosaurus CALDOX (CVCL_RR30)

Cell line name CALDOX
Accession CVCL_RR30
Resource Identification Initiative To cite this cell line use: CALDOX (RRID:CVCL_RR30)
Comments Group: Triple negative breast cancer (TNBC) cell line.
Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Disease Breast carcinoma (NCIt: C4872)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1110 (CAL-51)
Sex of cell Female
Age at sampling 45Y
Category Cancer cell line

PubMed=23122841; DOI=10.1016/j.bcp.2012.10.020
Raguz S., Adams C., Masrour N., Rasul S., Papoutsoglou P., Hu Y., Cazzanelli G., Zhou Y., Patel N., Coombes C., Yague E.
Loss of O(6)-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells.
Biochem. Pharmacol. 85:186-196(2013)